Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 13, 1998, Pages 7699-7704

  Sora, Ichiro ^a   Wichems, Christine ^b   Takahashi, Nobuyuki ^a   Li, Xiao Fei ^a   Zeng, Zhizhen ^a   Revay, Randal ^a   Lesch, Klaus Peter ^c   Murphy, Dennis L ^b   Uhl, George R ^a,d,e  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Molecular Neurobiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; SEROTONIN TRANSPORTER; SODIUM CHANNEL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RADIOASSAY; REWARD;

ANIMALS; CARRIER PROTEINS; CHOICE BEHAVIOR; COCAINE; CONDITIONING (PSYCHOLOGY); DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; RESTRICTION MAPPING; REWARD; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

ANIMALIA;

EID: 0032560560     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.13.7699     Document Type: Article

References (34)

1. Substance Abuse and Mental Health Services Administration (1996) National Household Survey on Drug Abuse: Population Estimates 1995 (U.S. Dept. of Health and Human Services, Rockville, MD).
2. Caroll, F. I., Lewis, A. H. & Biswas, J. (1994) Pharm. News 1, 11-17.
3. Spealman, R. D., Madras, B. K. & Bergman, J. (1989) J. Pharmacol. Exp. Ther. 251, 142-149.
4. Kuhar, M. J., Ritz, M. C. & Boja, J. W. (1991) Trends Neurosci. 14, 299-302.
5. Roberts, D. C., Corcoran, M. E. & Fibiger, H. C. (1977) Pharmacol. Biochem. Behav. 6, 615-620.
6. Roberts, D. C. & Koob, G. F. (1982) Pharmacol. Biochem. Behav. 17, 901-904.
7. Pettit, H. O., Ettenberg, A., Bloom, F. E. & Koob, G. F. (1984) Psychopharmacology (Berlin) 84, 167-173.
8. Di Chiara, G. & Imperato, A. (1988) Proc. Natl. Acad. Sci. USA 85, 5274-5278.
9. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. (1996) Nature (London) 379, 606-612.
10. Uhl, G. R., Vandenbergh, D. J. & Miner, L. L. (1996) Curr. Biol. 6, 935-936.
11. Wilson, M. C. & Schuster, C. R. (1976) Pharmacol. Biochem. Behav. 4, 207-210.
12. Yanagita, T., Wakasa, Y. & Oinuma, N. (1982) Jitchuken Zenrinsho Kenkyuho 8, 247-257.
13. Chait, L. D., Uhlenhuth, E. H. & Johanson, C. E. (1987) J. Pharmacol. Exp. Ther. 242, 777-783.
14. Javitch, J. A., Blaustein, R. O. & Snyder, S. H. (1984) Mol. Pharmacol. 26, 35-44.
15. Cooper, J. R., Bloom, F. E. & Roth, R. H. (1991) The Biochemical Basis of Neuropharmacology (Oxford Univ. Press, New York).
16. Uhl, G. R. & Hartig, P. R. (1992) Trends Pharmacol. Sci. 13, 421-425.
17. Kleven, M. S. & Woolverton, W. L. (1993) Drug Alcohol Depend. 31, 149-158.
18. Spealman, R. D. (1993) Psychopharmacology (Berlin) 112, 93-99.
19. Walsh, S. L., Preston, K. L., Sullivan, J. T., Fromme, R. & Bigelow, G. E. (1994) J. Clin. Psychopharmacol. 14, 396-407.
20. Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D., Heils, A., Mossner, R., Westphal, H. & Lesch, K. (1998) Mol. Pharmacol. 53, 649-655.
21. Martin, I. M., Ortmann, R. & Fibiger, H. C. (1985) Brain Res. 332, 59-67.
22. Miner, L. L., Drago, J., Chamberlain, P. M., Donovan, D. & Uhl, G. R. (1995) NeuroReport 6, 2314-2316.
23. Joyner, A. L. (1993) Gene Targeting, A Practical Approach (Oxford Univ. Press, New York).
24. Donovan, D. M., Vandenbergh, D. J., Perry, M. P., Bird, G. S., Ingersoll, R., Nanthakumar, E. & Uhl, G. R. (1995) Brain Res. Mol. Brain Res. 30, 327-335.
25. Li, E., Bestor, T. H. & Jaenisch, R. (1992) Cell 69, 915-926.
26. Boja, J. W., Carroll, F. I., Rahman, M. A., Philip, A., Lewin, A. H. & Kuhar, M. J. (1990) Eur. J. Pharmacol. 184, 329-332.
27. Freed, C., Revay, R., Vaughan, R. A., Kriek, E., Grant, S., Uhl, G. R. & Kuhar, M. J. (1995) J. Comp. Neurol. 359, 340-349.
28. Miner, L. L. & Marley, R. J. (1995) Psychopharmacology (Berlin) 122, 209-214.
29. Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R. S., Donovan, D. M., Miner, L. L. & Uhl, G. R. (1997) Proc. Natl. Acad. Sci. USA 94, 1544-1549.
30. Catterall, W. & Mackie, K. (1996) in Goodman & Gilman's The Pharmacological Basis of Therapeutics, eds. Hardman, G. G., Gilman, A. & Limbird, L. L. (McGraw-Hill, New York), pp. 331-347.
31. Hoffman, B. B. & Lefkowitz, R. J. (1996) in Goodman & Gilman's The Pharmacological Basis of Therapeutics, eds. Hardman, G. G., Gilman, A. & Limbird, L. L. (McGraw-Hill New York), pp. 199-248.
32. Weidman, S. J. (1955) J. Physiol. 129, 568-582.
33. Madras, B. K., Fahey, M. A., Bergman, J., Canfield, D. R. & Spealman, R. D. (1989) J. Pharmacol. Exp. Ther. 251, 131-141.
34. Reith, M. E. A. (1991) in Cocaine: Pharmacology, Physiology, and Clinical Strategies, eds. Lakoski, J. M., Galloway, M. P. & White, F. J. (CRC, Boca Raton, FL), pp. 203-227.